NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The nuclear factor NF-kappaB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cancer. These proteins are implicated in epidermal squamous cell carcinoma in mice, however, the potential effects of altering their function are uncertain. Whereas inhibition of NF-kappaB enhances apoptosis in certain tumours, blockade of NF-kappaB predisposes murine skin to squamous cell carcinoma. Because therapeutics inhibiting Ras and NF-kappaB pathways are being developed to treat human cancer, it is essential to assess the effects of altering these regulators. The medical relevance of murine studies is limited, however, by differences between mouse and human skin, and by the greater ease of transforming murine cells. Here we show that in normal human epidermal cells both NF-kappaB and oncogenic Ras trigger cell-cycle arrest. Growth arrest triggered by oncogenic Ras can be bypassed by IkappaBalpha-mediated blockade of NF-kappaB, generating malignant human epidermal tissue resembling squamous cell carcinoma. Human cell tumorigenesis is dependent on laminin 5 and alpha6beta4 integrin. Thus, IkappaBalpha circumvents restraints on growth promotion induced by oncogenic Ras and can act with Ras to induce invasive human tissue neoplasia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon cotransfection with the human TERT gene, defined sets of oncogenes, specifically activated H-RAS, SV40 large T antigen and SV40 small t antigen, resulted in the efficient malignant transformation of human fibroblasts (96).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [96]
Citations
Cites
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Cutaneous Squamous-Cell Carcinoma
Alam, M., & Ratner, D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441306 · Cited by 1,305
Nonmelanoma skin cancer in the United States: Incidence
Miller, D. L., & Weinstock, M. A. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81509-5 · Cited by 1,098 · cited 1×
“jpg" NDATA ITEM> ]> The nuclear factor NF-κB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cance”
BackgroundHuman breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878 · cited 1×
“Ectopic subcutaneous tumour formation in mice often requires administration of matrigel or fibroblast-derived matri”
BackgroundBlocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831 · cited 1×
“Because therapeutics inhibiting Ras and NF-κB pathways are being developed to treat human cance”
Background
Cited by
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
“Similarly, inhibition of NF-κB in primary human keratinocytes promoted their Ras-mediated transformatio”
BackgroundNF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
“In fact, NF-κB inhibition in the epidermis promotes the development of spontaneous squamous-cell carcinoma, which is another example of the antitumorigenic function of NF-κB in certain cell type”
BackgroundSignalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
“However, by contrast, a recent report showed that NF-κB blockade can trigger invasive epidermal neoplasi”
BackgroundIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
“In skin, for example, terminal differentiation is the mode by which keratinocytes die, and in contrast to colitis-associated and hepatocellular carcinoma, inhibiting NFκB in skin keratinocytes promotes epidermal hyperplasia and the development of spontaneous squamous cell carcinoma”
BackgroundAggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
NF‐κB and the link between inflammation and cancer
DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,482
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Inflammation meets cancer, with NF-κB as the matchmaker
Ben-Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,373
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
NF-κB, an Active Player in Human Cancers
Xia, Y., Shen, S., & Verma, I. M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0112 · Cited by 1,213
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046
“Nonetheless, the situation is complex, as mutations leading to hyperactivation of NF-kB occur in the activated B-cell-like (ABC) subtype of DLBCLs, where the pro-oncogenic functions of NF-kB likely predominate (Compagno et al. 2009; Davis et al. 2010).”
BackgroundHuber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421358 · Cited by 1,033
“org Volume 114 Number 4 August 2004 579 onstrated to be necessary for Ras-mediated induction of invasive epidermal tumors resembling squamous cell carcinomas (41).”
BackgroundLoss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
“However, it has recently been shown that inhibition of NF-κB in keratinocytes contributes to neoplasi”
Cooper, J., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 945
“Mechanistic studies in carcinoma stem cells resistant to EGFR inhibitors have linked the ability of αvβ3 to promote stemness to activation of KRas and signaling to NF-κB (Seguin et al., 2014) (Figure 6B).”
BackgroundInfluentialNuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
“…should be noted that while NF-kB contributes to oncogenesis in a majority of cell types, its IkBamediated suppression in keratinocytes was recently demonstrated to be necessary for Ras-mediated induction of invasive epidermal tumors resembling squamous cell carcinoma (Dajee et al., 2003).”
BackgroundGupta, S. C., Hevia, D., Patchva, S., Park, B., Koh, W., & Aggarwal, B. B. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4414 · Cited by 732
Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells
Wong, D. J., Liu, H., Ridky, T. W., Cassarino, D., Segal, E., & Chang, H. Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.02.009 · Cited by 720
“Primary human keratinocytes transduced with oncogenic Ras and a stabilized mutant of the NF-κB repressor IκBα, that are then grafted onto immunodeficient scid mice, produce well-differentiated squamous cell carcinomas (SCCs) that are phenotypically indistinguishable from authentic human lesions (Dajee et al., 2003).”
BackgroundNuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
“For example, one report demonstrated that inhibition of NF-kB in skin leads to oncogenic potential and potentiates H-Rasinduced transformation (Dajee et al., 2003).”
BackgroundFrom keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
Ratushny, V., Gober, M. D., Hick, R., Ridky, T. W., & Seykora, J. T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57415 · Cited by 545
Demory Beckler, M., Higginbotham, J. N., Franklin, J. L., Ham, A.-J., Halvey, P. J., Imasuen, I. E., Whitwell, C., Li, M., Liebler, D. C., & Coffey, R. J. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.022806 · Cited by 524
Ling, J., Kang, Y., Zhao, R., Xia, Q., Lee, D.-F., Chang, Z., Li, J., Peng, B., Fleming, J. B., Wang, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.006 · Cited by 513
Good cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489
“Some of the best evidence for NF-kB functioning as a tumor suppressor comes from work demonstrating that NF-kB inhibition in the epidermis results in hyperplasia and the development of squamous cell carcinomas.87–89 In addition, RelA is frequently excluded from the nucleus in human sporadic small cell carcinomas (SCC)…”
BackgroundInfluentialRole of the NFκB-signaling pathway in cancer
Xia, L., Tan, S., Zhou, Y., Lin, J., Wang, H., Oyang, L., Tian, Y., Liu, L., Su, M., Wang, H., et al. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s161109 · Cited by 460
“125 The overexpression of I κ B α induced by ablation of IKK β can enhance the stability of I κ B by inhibition of the phosphorylated I κ B α protein, resulting in inactivation of canonical NF κ B.”
The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M., & Franzoso, G. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.001 · Cited by 447
The dark side of Ras: regulation of apoptosis
Cox, A. D., & Der, C. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207111 · Cited by 437
“Recently, Khavari and co-workers (Dajee et al., 2003) elegantly demonstrated that super-repressor I-kBa blockade of NF-kB abrogates Ras-mediated cell cycle arrest to produce malignant tissue mimicking squamous cell carcinoma.”
BackgroundHe, G., Yu, G.-Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H. L., & Karin, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.048 · Cited by 427
“Similar findings were made in squamous cell carcinoma (SCC), where NF-κB was shown to inhibit keratinocyte proliferation and Rasinduced tumorigenesis through negative regulation of JNK activity, whose exact mechanism was not identified (Dajee et al., 2003; Zhang et al., 2004).”
Current insights into the regulation of programmed cell death by NF-κB
Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209938 · Cited by 407
“Furthermore, inhibition of NF-kB activity combined with expression of oncogenic Ras in epidermal keratinocytes leads to invasive neoplasia with features similar to those of squamous cell carcinoma (Dajee et al., 2003).”
BackgroundGinos, M. A., Page, G. P., Michalowicz, B. S., Patel, K. J., Volker, S. E., Pambuccian, S. E., Ondrey, F. G., Adams, G. L., & Gaffney, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2144 · Cited by 407
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
Mauro, C., Leow, S. C., Anso, E., Rocha, S., Thotakura, A. K., Tornatore, L., Moretti, M., De Smaele, E., Beg, A. A., Tergaonkar, V., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2324 · Cited by 394
“The role of NF-κB in Ras-induced transformation, however, remains controversia”
NF-κB and IKK as therapeutic targets in cancer
Kim, H. J., Hawke, N., & Baldwin, A. S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401877 · Cited by 391
“promote oncogenesis in a variety of tumors, evidence has been presented that inhibition of NF-kB in skin leads to oncogenic potential and potentiates Ras-induced transformation.(31) One mechanism to explain this concept is that inhibition of NF-kB in the skin leads to JNK activation,(32) a finding consistent with seve…”
ResultActive Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB
Campbell, K. J., Rocha, S., & Perkins, N. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00131-5 · Cited by 386
Cell-Extracellular Matrix Interactions in Normal and Diseased Skin
Watt, F. M., & Fujiwara, H. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005124 · Cited by 384
“Such studies have shown that the ability of oncogenic Ras and NF-kB blockade to convert human epidermis into squamous cell carcinoma is dependent on laminin-332 (laminin-5) and the a6b4 integrin (Dajee et al. 2003).”
BackgroundTumour necrosis factor-α as a tumour promoter
Szlosarek, P., Charles, K. A., & Balkwill, F. R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.012 · Cited by 366
Valentine, R., Dawson, C. W., Hu, C., Shah, K. M., Owen, T. J., Date, K. L., Maia, S. P., Shao, J., Arrand, J. R., Young, L. S., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-1 · Cited by 353
“[40] showed in SCC biopsies that p65 staining was predominantly cytosolic.”
BackgroundContribution of stem cells and differentiated cells to epidermal tumours
Owens, D. M., & Watt, F. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1096 · Cited by 346
“, and RAS can contribute to the development of human SCC”
BackgroundHuman papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells
Martinez, I., Gardiner, A. S., Board, K. F., Monzon, F. A., Edwards, R. P., & Khan, S. A. (2008) · Oncogene · doi:10.1038/sj.onc.1210919 · Cited by 340
“LAMB3 increases cell migration and tumorigenicity in severe combined immunodeficient mice, and in collaboration with its ligand a6b4-integrin promotes tumorigenesis in human keratinocytes (Dajee et al., 2003; Calaluce et al., 2004).”
BackgroundMultifaceted link between cancer and inflammation
Sethi, G., Shanmugam, M. K., Ramachandran, L., Kumar, A. P., & Tergaonkar, V. (2012) · Bioscience Reports · doi:10.1042/bsr20100136 · Cited by 333
Apoptosis, Stem Cells, and Tissue Regeneration
Bergmann, A., & Steller, H. (2010) · Science Signaling · doi:10.1126/scisignal.3145re8 · Cited by 328
“Activation of both JNK and Stat3 has been implicated in several types of human cancer (106, 107), and Stat3 function is critically required for the development of HCC (108, 109).”
BackgroundLefort, K., Mandinova, A., Ostano, P., Kolev, V., Calpini, V., Kolfschoten, I., Devgan, V., Lieb, J., Raffoul, W., Hohl, D., et al. (2007) · Genes & Development · doi:10.1101/gad.1484707 · Cited by 305
Laminin 332 in squamous-cell carcinoma
Marinkovich, M. P. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2089 · Cited by 299
Self-citationNF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 298
“The tumor suppressing activity of NF-kB in keratinocytes was explained either by inhibition of cell cycle progression [47,48] or by downmodulation of c-Jun”
Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer
Van Waes, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2221 · Cited by 292
Srikrishna, G., & Freeze, H. H. (2009) · Neoplasia · doi:10.1593/neo.09284 · Cited by 275
Stem-cell hierarchy in skin cancer
Perez-Losada, J., & Balmain, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1095 · Cited by 268
“Removal of this inhibition by expression of IκBα has been shown to synergize with activated Ras to produce squamous carcinoma”
BackgroundInflammation-associated cancer: NF-κB is the lynchpin
Li, Q., Withoff, S., & Verma, I. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.003 · Cited by 268
p120-Catenin Mediates Inflammatory Responses in the Skin
Perez-Moreno, M., Davis, M. A., Wong, E., Pasolli, H. A., Reynolds, A. B., & Fuchs, E. (2006) · Cell · doi:10.1016/j.cell.2005.11.043 · Cited by 264
O-GlcNAcylation: A New Cancer Hallmark?
Fardini, Y., Dehennaut, V., Lefebvre, T., & Issad, T. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00099 · Cited by 263
NF-κB: tumor promoter or suppressor?
Perkins, N. D. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.004 · Cited by 261
Tumor Promotion via Injury- and Death-Induced Inflammation
Kuraishy, A., Karin, M., & Grivennikov, S. I. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.006 · Cited by 261
“Likewise and as seen in the liver, inhibition of epidermal NF-kB activation results in enhanced skin tumorigenesis (Dajee et al., 2003).”
BackgroundNotch tumor suppressor function
Dotto, G. P. (2008) · Oncogene · doi:10.1038/onc.2008.225 · Cited by 244
The Role of Apoptosis-Induced Proliferation for Regeneration and Cancer
Ryoo, H. D., & Bergmann, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008797 · Cited by 242
The Transcription Factor Nuclear Factor-kappa B and Cancer
Escárcega, R. O., Fuentes-Alexandro, S., García-Carrasco, M., Gatica, A., & Zamora, A. (2007) · Clinical Oncology · doi:10.1016/j.clon.2006.11.013 · Cited by 237
Keratinocyte Apoptosis in Epidermal Development and Disease
Raj, D., Brash, D. E., & Grossman, D. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700008 · Cited by 235
“Although NF-κB is a survival signal in KCs, as is noted above, and is activated in many tumor types, NFκB blockade in the skin, surprisingly, promotes KC transformation and SCC formation (Dajee et al., 2003).”
BackgroundPapa, S., Bubici, C., Zazzeroni, F., Pham, C. G., Kuntzen, C., Knabb, J. R., Dean, K., & Franzoso, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401865 · Cited by 235
“oncogenic H-ras to induce malignant transformation.(16,105,143,144) NF-kB might exert a similar tumor-suppressor function also in the liver, because (while impeding tumor progression) conditional deletion of IKKb in hepatocytes appears to enhance tumor initiation in a model of chemical carcinogenesis.”
BackgroundProteases, Extracellular Matrix, and Cancer
DeClerck, Y. A., Mercurio, A. M., Stack, M. S., Chapman, H. A., Zutter, M. M., Muschel, R. J., Raz, A., Matrisian, L. M., Sloane, B. F., Noel, A., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63200-2 · Cited by 232
“Studies performed by Mercurio’s group and others have established an important role for the 6 4 integrin in the progression of many carcinomas.(5,6) This integrin resides on the basal surface of epithelia where it anchors the epithelium to the underlying basement membrane in rigid structures termed hemidesmosomes.”
BackgroundNuclear factor-κB: a friend or a foe in cancer?
Shishodia, S., & Aggarwal, B. B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.026 · Cited by 228
“have shown that NF-kB blockade triggers invasive human epidermal neoplasia [107].”
Doehn, U., Hauge, C., Frank, S. R., Jensen, C. J., Duda, K., Nielsen, J. V., Cohen, M. S., Johansen, J. V., Winther, B. R., Lund, L. R., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.002 · Cited by 227
“For instance, laminin 332 and a6/b4-integrin are required for RAS to induce squamous cell carcinomas (Dajee et al., 2003).”
Liu, M., Sakamaki, T., Casimiro, M. C., Willmarth, N. E., Quong, A. A., Ju, X., Ojeifo, J., Jiao, X., Yeow, W.-S., Katiyar, S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0732 · Cited by 227
Darido, C., Georgy, S. R., Wilanowski, T., Dworkin, S., Auden, A., Zhao, Q., Rank, G., Srivastava, S., Finlay, M. J., Papenfuss, A. T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.014 · Cited by 224
“However, mutations in Ras isoforms are found in only 22% of SCCs (Khavari and Rinn, 2007), although some tumors can display increased levels of active Ras-GTP in the absence of a mutation (Dajee et al., 2003).”
BackgroundHan, G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24399 · Cited by 224
K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review
Aviel-Ronen, S., Blackhall, F. H., Shepherd, F. A., & Tsao, M.-S. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.030 · Cited by 224
Lizzul, P. F., Aphale, A., Malaviya, R., Sun, Y., Masud, S., Dombrovskiy, V., & Gottlieb, A. B. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23735.x · Cited by 212
Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia
Ridky, T. W., Chow, J. M., Wong, D. J., & Khavari, P. A. (2010) · Nature Medicine · doi:10.1038/nm.2265 · Cited by 217
Self-citationImpaired Notch Signaling Promotes De novo Squamous Cell Carcinoma Formation
Proweller, A., Tu, L., Lepore, J. J., Cheng, L., Lu, M. M., Seykora, J., Millar, S. E., Pear, W. S., & Parmacek, M. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0793 · Cited by 213
Cooper, S., & Bowden, G. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780809714 · Cited by 204
“furthered these concerns by observing that the blocking of NF-κB activation in human epidermal cells expressing oncogenic Ras leads to the generation of malignant human epidermal tissue that resemble SCCs [67].”
BackgroundCytochrome P450-derived eicosanoids: the neglected pathway in cancer
Panigrahy, D., Kaipainen, A., Greene, E. R., & Huang, S. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9264-x · Cited by 199
“Both inhibition and activation of the nuclear factor-kappaB (NF-κB) protein complex can promote carcinogenesis [73–75].”
BackgroundUse of human tissue to assess the oncogenic activity of melanoma-associated mutations
Chudnovsky, Y., Adams, A. E., Robbins, P. B., Lin, Q., & Khavari, P. A. (2005) · Nature Genetics · doi:10.1038/ng1586 · Cited by 198
“This may be possible in skin, which can be regenerated from primary human cells on immunodeficient mice to accurately recapitulate the three-dimensional architecture, matrix elements and gene expression patterns of adult human tissu”
BackgroundSelf-citationKolev, V., Mandinova, A., Guinea-Viniegra, J., Hu, B., Lefort, K., Lambertini, C., Neel, V., Dummer, R., Wagner, E. F., & Dotto, G. P. (2008) · Nature Cell Biology · doi:10.1038/ncb1750 · Cited by 186
Uribe, P., & Gonzalez, S. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.03.002 · Cited by 177
Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg, N. J., Rajadurai, P., & Raab‐Traub, N. (2003) · PubMed · Cited by 179
New roles for integrins in squamous-cell carcinoma
Janes, S. M., & Watt, F. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1817 · Cited by 178
“One of the most striking examples of this is the observation that laminin 5 and α 6 β 4 cooperate with Ras and inhibitor of κBα (IκBα) to induce primary human epidermal keratinocytes to form SCCs in immune-deficient mic”
BackgroundLaminin-binding integrins and their tetraspanin partners as potential antimetastatic targets
Stipp, C. S. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001355 · Cited by 165
Rousselle, P., & Scoazec, J. Y. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.026 · Cited by 165
Müller, E. J., Williamson, L., Kolly, C., & Suter, M. M. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701248 · Cited by 162
“another potential effector activated downstream of E-cadherin/Akt and GSKb is NF-kB/RelA, which also can control cell-cycle exit in human and mouse keratinocytes (Dajee et al., 2003; Zhang et al., 2004).”
BackgroundThe opposing roles of laminin-binding integrins in cancer
Ramovš, V., Molder, L. T., & Sonnenberg, A. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.08.007 · Cited by 167
Advances in cutaneous squamous cell carcinoma
Winge, M. C. G., Kellman, L. N., Guo, K., Tang, J. Y., Swetter, S. M., Aasi, S. Z., Sarin, K. Y., Chang, A. L. S., & Khavari, P. A. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00583-5 · Cited by 166
Self-citationModelling cancer in human skin tissue
Khavari, P. A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1838 · Cited by 176
Self-citationNF-κB signaling pathway in tumor microenvironment
Cao, Y., Yi, Y., Han, C., & Shi, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1476030 · Cited by 169
NF‐κB/Egr‐1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death
Thyss, R., Virolle, V., Imbert, V., Peyron, J., Aberdam, D., & Virolle, T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600501 · Cited by 167
“Furthermore, it is now well accepted that inhibition of NF-kB activation, especially RelA containing complex, promotes growth and carcinogenesis in skin (Dajee et al, 2003; Takao et al, 2003).”
BackgroundLipscomb, E. A., & Mercurio, A. M. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5133-4 · Cited by 152
“Although it was known that expression of α6β4 increases markedly in squamous cell carcinomas (SCC) but not in basal cell carcinomas [53], which also originate from epidermal cells but are relatively nonmetastatic, the report that α6β4 may be involved in the formation of SCCs was rather surprising [42].”
BackgroundMethodInfluentialLangerhans Cells Facilitate Epithelial DNA Damage and Squamous Cell Carcinoma
Modi, B. G., Neustadter, J., Binda, E., Lewis, J., Filler, R. B., Roberts, S. J., Kwong, B. Y., Reddy, S., Overton, J. D., Galan, A., et al. (2012) · Science · doi:10.1126/science.1211600 · Cited by 148
Michels, N., van Aart, C., Morisse, J., Mullee, A., & Huybrechts, I. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103177 · Cited by 154
Benitah, S. A., Valerón, P. F., Aelst, L. V., Marshall, C. J., & Lacal, J. C. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.10.002 · Cited by 164
Lippens, S., Hoste, E., Vandenabeele, P., Agostinis, P., & Declercq, W. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0324-z · Cited by 175
“Cell cycle arrest induced by oncogenic Ras can be overcome by blocking NF-jB, as shown by IkBa overexpression [212], in which case NF-jB acts as a tumor-suppressor.”
BackgroundType VII Collagen Is Required for Ras-Driven Human Epidermal Tumorigenesis
Ortiz-Urda, S., Garcia, J., Green, C. L., Chen, L., Lin, Q., Veitch, D. P., Sakai, L. Y., Lee, H., Marinkovich, M. P., & Khavari, P. A. (2005) · Science · doi:10.1126/science.1106209 · Cited by 143
Self-citationPacifico, F., & Leonardi, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.032 · Cited by 165
Multiple Functions of the Integrin α6β4 in Epidermal Homeostasis and Tumorigenesis
Wilhelmsen, K., Litjens, S. H. M., & Sonnenberg, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2877-2886.2006 · Cited by 144
“In fact, the inhibition of NF-B in the presence of activated Ras can trigger tumorigenesis in the human epidermis, which is dependent on 64 ( 10 ).”
BackgroundScholl, F. A., Dumesic, P. A., Barragan, D. I., Harada, K., Bissonauth, V., Charron, J., & Khavari, P. A. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.009 · Cited by 171
Self-citationRegulation of Programmed Cell Death by NF-κB and its Role in Tumorigenesis and Therapy
Fan, Y., Dutta, J., Gupta, N., Fan, G., & Gélinas, C. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_11 · Cited by 156
Whitehouse, A. S., & Tisdale, M. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601132 · Cited by 136
“While in most cell types, NF-kB seems to promote cell proliferation and protect against apoptosis, in skin it appears to oppose proliferation (Dajee et al, 2003).”
BackgroundLesina, M., Wörmann, S. M., Morton, J., Diakopoulos, K. N., Korneeva, O., Wimmer, M., Einwächter, H., Sperveslage, J., Demir, I. E., Kehl, T., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86477 · Cited by 128
Lefort, K., & Dotto, G. P. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.017 · Cited by 156
Ahn, K. S., Sethi, G., Jain, A. K., Jaiswal, A. K., & Aggarwal, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601162200 · Cited by 134
Condorelli, A. G., Dellambra, E., Logli, E., Zambruno, G., & Castiglia, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225707 · Cited by 141
Metadata
- Authors
- Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., & Khavari, P. A.
- Affiliations
- VA Palo Alto Health Care System (US)
- Corresponding author
- Khavari, Paul A.
- ORCID
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6923
- Pages
- 639-643
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1986301169
- Cited by
- 535
- References
- 32
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 13 · 2017: 7 · 2016: 20 · 2015: 21 · 2014: 22 · 2013: 25 · 2012: 23
- FWCI
- 19.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, oncogenic Ras, IκBα, cell cycle arrest, laminin-5, alpha6beta4 integrin, carcinogenesis, skin cancer
- MeSH terms
- NF-KappaB Inhibitor alpha, Kalinin, Animals, Cell Division, Epidermis, Humans, Mice, Nude, Neoplasm Invasiveness, Neoplasms, Genes, ras, Transduction, Genetic, Keratinocytes, Oncogene Protein p21(ras), Cell Adhesion Molecules, NF-kappa B, Mice, SCID, Telomere, Apoptosis, Cyclin-Dependent Kinases, I-kappa B Proteins, Integrin alpha6beta4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.